Regional differences in healthcare costs at the end of life: an observational study using Swiss insurance claims data

被引:5
作者
Bahler, Caroline [1 ]
Rapold, Roland [1 ]
Signorell, Andri [1 ]
Reich, Oliver [1 ]
Panczak, Radoslaw [2 ]
Blozik, Eva [1 ,3 ]
机构
[1] Helsana Insurance Grp, Dept Hlth Sci, Zurich, Switzerland
[2] Univ Queensland, Sch Earth & Environm Sci, Queensland Ctr Populat Res, Brisbane, Qld, Australia
[3] Univ Med Ctr Freiburg, Dept Med, Freiburg, Germany
关键词
End-of-life care; Health care costs; Cause of death; Regional variation; Claims data; Intensity of treatment; INTENSITY; CANCER; MORTALITY; CULTURE;
D O I
10.1007/s00038-020-01428-w
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives We evaluated healthcare cost differences at the end of life (EOL) between language regions in Switzerland, accounting for a comprehensive set of variables, including treatment intensity. Methods We evaluated 9716 elderly who died in 2014 and were insured at Helsana Group, with data on final cause of death provided by the Swiss Federal Statistical Office. EOL healthcare costs and utilization, >= 1 ICU admission and 10 life-sustaining interventions (cardiac catheterization, cardiac assistance device implantation, pulmonary artery wedge monitoring, cardiopulmonary resuscitation, gastrostomy, blood transfusion, dialysis, mechanical ventilation, intravenous antibiotics, cancer chemotherapies) reimbursed by compulsory insurance were examined. Results Taking into consideration numerous variables, relative cost differences decreased from 1.27 (95% CI 1.19-1.34) to 1.06 (CI 1.02-1.11) between the French- and German-speaking regions, and from 1.12 (CI 1.03-1.22) to 1.08 (CI 1.02-1.14) between the Italian- and German-speaking regions, but standardized costs still differed. Contrary to individual factors, density of home-care nurses, treatment intensity, and length of inpatient stay explain a substantial part of these differences. Conclusions Both supply factors and health-service provision at the EOL vary between Swiss language regions and explain a substantial proportion of cost differences.
引用
收藏
页码:969 / 979
页数:11
相关论文
共 41 条
  • [1] Intensity of treatment in Swiss cancer patients at the end-of-life
    Bahler, Caroline
    Signorell, Andri
    Blozik, Eva
    Reich, Oliver
    [J]. CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 481 - 491
  • [2] Health Care Utilisation and Transitions between Health Care Settings in the Last 6 Months of Life in Switzerland
    Bahler, Caroline
    Signorell, Andri
    Reich, Oliver
    [J]. PLOS ONE, 2016, 11 (09):
  • [3] Development and Validation of Hospital "End-of-Life" Treatment Intensity Measures
    Barnato, Amber E.
    Farrell, Max H.
    Chang, Chung-Chou H.
    Lave, Judith R.
    Roberts, Mark S.
    Angus, Derek C.
    [J]. MEDICAL CARE, 2009, 47 (10) : 1098 - 1105
  • [4] Choosing wisely at the end of life: the crucial role of medical indication
    Borasio, Gian Domenico
    Jox, Ralf J.
    [J]. SWISS MEDICAL WEEKLY, 2016, 146 : w14369
  • [5] Variability of Intensive Care Admission Decisions for the Very Elderly
    Boumendil, Ariane
    Angus, Derek C.
    Guitonneau, Anne-Laure
    Menn, Anne-Marie
    Ginsburg, Christine
    Takun, Khalil
    Davido, Alain
    Masmoudi, Rafik
    Doumenc, Benoit
    Pateron, Dominique
    Garrouste-Orgeas, Maite
    Somme, Dominique
    Simon, Tabassome
    Aegerter, Philippe
    Guidet, Bertrand
    [J]. PLOS ONE, 2012, 7 (04):
  • [6] Evidence for overuse of medical services around the world
    Brownlee, Shannon
    Chalkidou, Kalipso
    Doust, Jenny
    Elshaug, Adam G.
    Glasziou, Paul
    Heath, Iona
    Nagpal, Somil
    Saini, Vikas
    Srivastava, Divya
    Chalmers, Kelsey
    Korenstein, Deborah
    [J]. LANCET, 2017, 390 (10090) : 156 - 168
  • [7] Busato A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-8
  • [8] Validity of caregiver-reported hospital admission in a study on the quality of care received by terminally ill cancer patients
    Chini, F.
    Rossi, P. Giorgi
    Costantini, M.
    Beccaro, M.
    Borgia, P.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2010, 63 (01) : 103 - 108
  • [9] Does long-term care subsidization reduce hospital admissions and utilization?
    Costa-Font, Joan
    Jimenez-Martin, Sergi
    Vilaplana, Cristina
    [J]. JOURNAL OF HEALTH ECONOMICS, 2018, 58 : 43 - 66
  • [10] De Pietro C, 2015, HEALT SYST TRANSIT, V17, P1